146-75-8

Upstream product

• 144-55-8 sodium hydrogencarbonate 
• 50-81-7 ascorbic acid 
• 7632-00-0 sodium nitrite 
• 1071558-27-4 (3R,4R,5S)-3,4,5,6-Tetrahydroxy-2-oxo-hexanoic acid methyl ester 
• 71-36-3 butan-1-ol 
• 3031-98-9 L-xylo-[2]hexulosonic acid methyl ester 
• 2797-51-5 quinoclamine 

Downstream Products

• 167095-80-9 3-O-retinoyl-L-ascorbic acid 
• 50-81-7 ascorbic acid 
• 52179-26-7 (-)-4-(2,2-dichlorocyclopropyl)phenol 
• 76003-76-4 1-benzyl-1H-[1,2,3]triazole-4-carboxylic acid methyl ester 
• 1007578-98-4 [4-(3-bromophenyl)-1H-1,2,3-triazol-1-yl]methyl 2,2-dimethylpropanoate 
• 1259489-71-8 2-C-benzyl-α-L-xylo-hex-3-ulofuranosono-1,4-lactone 
• 86404-08-2 (2R)-3-benzyloxy-2-[(1S)-1,2-dihydroxyethyl]-4-hydroxy-2H-furan-5-one 
• 86404-07-1 O³-benzyl-O⁵,O⁶-(1-methylethylidene)-L-ascorbic acid 
• 1600513-03-8 (R)-8-amino-6-(5-azido-2-fluorophenyl)-6-(fluoromethyl)-4-thia-7-azaspiro[2.5]oct-7-ene 4,4-dioxide 
• 1600511-94-1 (R)-N-(5-(5-Amino-2-fluorophenyl)-2,2,5-trimethyl-1,1-dioxido-5,6-dihydro-2H-1,4-thiazin-3-yl)benzamide 
• 7306-96-9 L-threonic acid 
• 144-62-7 oxalic acid 
• 137460-62-9 methyl (2R,3S)-2,3,4-trihydroxybutanoate 
• 21730-93-8 L-threonic acid-4-lactone 

Relevant academic research and scientific papers

Synthesis and study of mutagenic properties of lupane triterpenoids containing 1,2,3-triazole fragments in the C-30 position

New derivatives of betulin, betulinic acid methyl ester, and their acetate analogs containing 1,2,3-triazole fragments in the C-30 position were synthesized. It was shown using the Ames test that 30-azidolup-20(29)-enes and 3β,28-diacetoxy-30-(4-R-1,2,3-t

Modified lupin proteins for preparation of water dispersible product forms of fat soluble compounds

The present invention relates to a process for the manufacture of a modified lupin protein, which comprises adjusting an aqueous solution or suspension of lupin proteins of native origin having a dry mass content of from 0.1 to 20% to pH 3 to 9, adding 0.

AGRICULTURAL COMPOSITION COMPRISING NITRIC OXIDE GENERATING AGENT

The invention discloses the use of a composition comprising at least one nitric oxide generating agent for increasing production of and/or retention of a plant organ.

Reverse Kleiner method for manufacturing nitrogen dioxide, nitric oxide, nitric acid, metallic ascorbates and alkyl ascorbates of vitamin C

In this invention new chemical reactions, new chemical processes are established, and these chemical reactions and chemical processes can be used with the system designed to produce nitrogen dioxide, nitric oxide, nitric acid as well as metallic ascorbates or alkyl ascorbates, either as main or as secondary products. Ascorbic acid solution is reacted at room temperature or at elevated temperature with either sodium nitrite or potassium nitrite or calcium nitrite or alkyl nitrite such as isobutyl nitrite or barium nitrite or silver nitrite solution. All the second reactants except alkyl nitrites such as isoamyl nitrite or isopropyl nitrite or isobutyl nitrite, as well as the first reactant, ascorbic acid, are in aqueous solutions. The reaction vessel contains the ascorbic acid solution; into this solution, under, certain pressure, is delivered the choosen aqueous nitrite solution. Gas mixture of nitrogen dioxide and nitric oxide is produced by addition of the choosen nitrite solution. The generated and collected gas mixture is then mixed with oxygen, thus the nitric oxide in the gas mixture converts—by reacting with oxygen—into nitrogen dioxide, then this homogeneous gas is dissolved in water, thus giving us nitric acid. In this chemical reaction system two sets of chemical reactions take place; one on the surface of the solution(s) that produces the main part of the gas mixture, and this is the major part of the chemical reaction system. In the liquid phase of the reaction processes form the metallic ascorbates as well as the alkyl ascorbates. All the same can be done with isoascorbic acid; the chemical reactions will go somewhat slower.

Dual iron containing nutritional supplement

The present invention relates to a nutritional supplement which comprises two different iron compounds, namely a rapidly dissolving iron compound and a slowly dissolving iron compound. The tablet is particularly contemplated for administration to women as

Method of making ascorbyl monophosphates

The present invention provides a method of making alkali metal and alkaline earth metal salts of L-ascorbic acid 2-monophosphate comprising reacting a L-ascorbic acid 2-polyphosphate under alkaline conditions with an alkali metal or alkaline earth metal s

Process for preparing ascorbic acid

Process for preparing pure ascorbic acid from 2-keto-L-gulonic acid or its sodium salt, by carrying out the following successive steps: esterification of 2-keto-L-gulonic acid or its sodium salt lactonization to sodium ascorbate optional separation of the sodium ascorbate displacement of the ascorbic acid from its salt separation of the sodium sulphate separation and purification of the ascorbic acid from its methanolic or aqueous-methanolic solution.

Process for the production of sodium or potassium L-ascorbate

In the process described for the production of sodium or potassium L-ascorbate, 2-keto-L-gulonic acid monhydrate is esterified with methanol. The esterification is only partial, that is, is not carried out until the esterification equilibrium is reached.

Ascorbic acid process

An improved process for the preparation of ascorbic acid and erythorbic acid is disclosed, the improvement comprising the removal of borate impurities from a 2-ketogulonate and a 2-ketogluconate prior to formation of the desired acids by base catalyzed cyclization.